JNIS editor Rob Tarr talks to Charles Kerber (University of California San Diego Medical Center) about Neucrylate, a new treatment for berry aneurysms.

Dr Kerber describes how his company developed the liquid embolic device, the results they’ve had using it, and future plans to get it into practice.

See also:

1-Hexyl n-cyanoacrylate compound (Neucrylate™ AN), a new berry aneurysm treatment. II. Rabbit implant studies: technique and histology http://bit.ly/17g34e7

1-Hexyl n-cyanoacrylate compound (Neucrylate™ AN), a new berry aneurysm treatment. I. Theoretical basis and laboratory evaluation http://bit.ly/YKON3y

1-Hexyl n-cyanoacrylate compound (Neucrylate™ AN), a new treatment for berry aneurysm. III: Initial clinical results http://bit.ly/10wAIx4